Please join our staff as we participate or present in the following oral and poster presentations at the 2017 ASCO Annual Meeting
Monday, June 5
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
7:30 AM – 9:15 AM
Location: Hall D1
HIGHLIGHTS OF THE DAY SESSION: Highlights of the Day Session II
7:30 AM – 7:50 AM
Central Nervous System Tumors
David M. Peereboom, MD – Discussant
8:00 AM – 9:15 AM
Location: S406
EDUCATION SESSION: Pancreatic Adenocarcinoma: Improving Prevention and Survivorship
Davendra Sohal, MD, MPH – Chair
8:00 AM – 8:20 AM
Best Practices in Management of Resectable Pancreatic Cancer: Emerging Standards for Adjuvant Therapy and Surveillance
Davendra Sohal, MD, MPH – Chair
8:00 AM – 9:15 AM
Location: E253cd
MEET THE PROFESSOR SESSION: Brain Metastases: Utilizing Genomics and Combining Treatment Modalities
8:00 AM – 8:20 AM
Innovative Targeted Therapeutic Approaches in Brain Metastases
Manmeet Singh Ahluwalia, MD – Speaker
8:00 AM – 11:30 AM
Location: Hall A
POSTER SESSION: Hematologic Malignancies — Leukemia, Myelodysplastic Syndromes, and Allotransplant
Abstract 7061: Phase I/II trial of glasdegib in patients with primary or secondary myelofibrosis
Poster Board: #261
Aaron Thomas Gerds, MS, MD – First Author
1:15 PM – 4:45 PM
Location: Hall A
POSTER SESSION: Central Nervous System Tumors
Abstract 2071: What drives patient outcomes in brain metastases: Number, volume, or biology?
Poster Board: #313
Rupesh Kotecha, MD – First Author
POSTER SESSION: Genitourinary (Prostate) Cancer
Abstract 5041: Clinical activity and safety of ASN001, a selective CYP17 lyase inhibitor, administered without prednisone in men with metastatic castration-resistant prostate cancer (mCRPC): A phase 1/2 clinical trial
Poster Board: #115
Jorge A. Garcia, MD – First Author
POSTER SESSION: Head and Neck Cancer
Abstract 6072: Prognostic factors associated with benefit to post-operative chemotherapy: A National Cancer Data Base analysis
Poster Board: #60
Jessica Lyn Geiger, MD – First Author
POSTER SESSION: Health Services Research, Clinical Informatics, and Quality of Care
Abstract 6557: Increase in time to initiating cancer therapy and association with worsened survival in curative settings: A U.S. analysis of common solid tumors
Poster Board: #379
Alok A. Khorana, MD – First Author
Abstract 6558: Minority patient reported attitudes regarding tissue donation and participation in cancer research
Poster Board: #380
Davendra Sohal, MD, MPH – First Author
Timing and type of side effects differ greatly from chemotherapy
Dedicated multidisciplinary teams support 84 ultra-rare cancers
Sessions explore treatment advances and multidisciplinary care
New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues
Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations
Early communication between oncologists and ophthalmologist warranted
Case-based course delves into latest treatment approaches
Long-term relationship building and engagement key to gaining community trust